dc.contributor.author | Cevik, Mehtap | |
dc.contributor.author | Cagatay, Penbe | |
dc.contributor.author | Caker, Selen | |
dc.contributor.author | Bayar, Elif | |
dc.contributor.author | SÜSLEYİCİ, BELGİN | |
dc.date.accessioned | 2022-02-18T09:30:26Z | |
dc.date.available | 2022-02-18T09:30:26Z | |
dc.date.issued | 2021 | |
dc.identifier.citation | Bayar E., Cevik M., Caker S., Cagatay P., SÜSLEYİCİ B., "DNA Damage in AML-12 Hepatocytes and 3T3-L1 Adipocytes Treated with Clopidogrel", CURRENT DRUG SAFETY, cilt.16, sa.3, ss.252-258, 2021 | |
dc.identifier.other | av_426e1be0-5722-4feb-b00d-a6e13cb6d73b | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/177366 | |
dc.identifier.uri | https://doi.org/10.2174/1574886315666210106141936 | |
dc.description.abstract | Background: Clopidogrel has been commonly prescribed as a selective P2Y(12) receptor antagonist to reduce heart attack and stroke risk. Nearly 10% of absorbed clopidogrel is metabolized to active forms by cytochrome P450 (CYP) enzymes in the liver and 90% to inactive clopidogrel carboxylate by esterases. | |
dc.language.iso | eng | |
dc.subject | Eczacılık | |
dc.subject | Temel Eczacılık Bilimleri | |
dc.subject | Yaşam Bilimleri | |
dc.subject | Temel Bilimler | |
dc.subject | Pharmacology | |
dc.subject | General Pharmacology, Toxicology and Pharmaceutics | |
dc.subject | Pharmacology, Toxicology and Pharmaceutics (miscellaneous) | |
dc.subject | Pharmacology (medical) | |
dc.subject | Pharmacy | |
dc.subject | Drug Guides | |
dc.subject | Life Sciences | |
dc.subject | Health Sciences | |
dc.subject | FARMAKOLOJİ VE ECZACILIK | |
dc.subject | Yaşam Bilimleri (LIFE) | |
dc.subject | Farmakoloji ve Toksikoloji | |
dc.subject | Sağlık Bilimleri | |
dc.title | DNA Damage in AML-12 Hepatocytes and 3T3-L1 Adipocytes Treated with Clopidogrel | |
dc.type | Makale | |
dc.relation.journal | CURRENT DRUG SAFETY | |
dc.contributor.department | Marmara Üniversitesi , , | |
dc.identifier.volume | 16 | |
dc.identifier.issue | 3 | |
dc.identifier.startpage | 252 | |
dc.identifier.endpage | 258 | |
dc.contributor.firstauthorID | 2774071 | |